Melissa Healy is a health and science reporter with the Los Angeles Times writing from the Washington, D.C., area. She covers prescription drugs, obesity, nutrition and exercise, and neuroscience, mental health and human behavior. She’s been at The Times for more than 30 years, and has covered national security, environment, domestic social policy, Congress and the White House. As a baby boomer, she keenly follows trends in midlife weight gain, memory loss and the health benefits of red wine.
Latest From This Author
-
Los científicos temen un “escenario de pesadilla” en el que un paciente se infecte por dos cepas diferentes de coronavirus que intercambien mutaciones y se vuelvan más peligrosas.
-
Mixing and matching doses of different COVID-19 vaccines was an idea that scientists dismissed out of hand. Now they’re taking it seriously.
-
While coronavirus variants remain a threat, health experts say they are hopeful that masks and rising vaccination rates can blunt potential new waves.
-
California has surpassed 50,000 COVID-19 deaths, a tally that came as Los Angeles County reported a backlog of more than 800
-
Scientists fear “nightmare scenario” where a patient is infected by two different coronavirus strains that swap mutations and become more dangerous.
-
La cepa de coronavirus autóctona de California es más transmisible que sus predecesoras, es más resistente a las vacunas y puede causar casos más graves de COVID-19.
-
California’s coronavirus strain is more transmissible than its predecessors, is more resistant to vaccines and may cause more severe cases of COVID-19.
-
COVID-19 vaccines may be less effective against the coronavirus strain from South Africa, but scientists remain confident that humans have the upper hand.
-
Coronavirus variant first seen in L.A. now accounts for about half of Southern California’s infections and has spread to 18 states and six countries.
-
La administración Biden está impulsando los esfuerzos para identificar y rastrear las variantes del coronavirus para ayudar a los científicos a ver hacia dónde se dirige la pandemia.